OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 16, 2018
The new 73,000-square-foot facility is one of several expansions to support the company’s biologics testing capabilities.
March 07, 2018
Grand River Aseptic Manufacturing announces first planned investment in capacity expansion.
In selling its contrast media business, Hovione will focus on API and drug product development and manufacturing.
March 06, 2018
Twenty-first century drug development challenges sponsors and contract partners to collaborate more closely, using tools such as model-based simulation.
March 02, 2018
Catalent completes $4.6 million expansion at Singapore clinical supply facility and marks 20 years in the region.
Development and adoption of new technologies create challenges that may take years to resolve.
Assessing potential formulation and manufacturing issues in early development phases can improve a drug’s chances for success.
Robert Iser of PAREXEL Consulting answers questions regarding the regulatory expectations of quality agreements and how companies can ensure the quality and safety of their products.
February 23, 2018
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
February 22, 2018
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.